6505--japanese encephalitis virus vaccine ixiaro

Award Notice Posted

Solicitation number
36C25227N0099
Agency
Awarded
Set-aside
No set-aside

Opportunity facts

Contract number
36F79725D024936C25227N0099

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a contract to Valneva USA, Inc. for $787,392 to supply Japanese Encephalitis Virus Vaccine (IXIARO) on October 1, 2026.

The award was made under an existing FSS Contract Number 36F79725D0249 as a delivery order. The acquisition was justified under GSAR 538.7104-4 (proprietary data limiting competition), as IXIARO is the only JE vaccine licensed and available for use in the United States; the product is manufactured by Valneva Scotland Ltd. in Livingston, Scotland. The vaccine will support the Captain James A. Lovell Federal Healthcare Center in North Chicago, Illinois, and is required for Navy recruits prior to deployment for training. The procurement was conducted under PSC 6505 and NAICS 325412 (pharmaceutical preparation manufacturing). No set-aside was used, and no Recovery Act funds were utilized.

Notice text

Awarded contract 36F79725D024936C25227N0099 to VALNEVA USA, INC. for 787392.00 on 2026-10-01.

Files

File Type Posted
36F79725D0249 36C25227N0099_1.docx DOCX document
GSAR 538 Limiting_Sources_Justification_OVER_SAT.pdf PDF

Notice history

Notice Type Posted
6505--japanese encephalitis virus vaccine ixiaro Latest Award Notice
6505--japanese encephalitis virus vaccine ixiaro Award Notice
This notice Original Award Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors